159 related articles for article (PubMed ID: 32869851)
1. Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer.
Lv P; Zhang Z; Hou L; Zhang Y; Lu L; Wang C; Shi F
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869851
[TBL] [Abstract][Full Text] [Related]
2. The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis.
Zeng H; Fang C; Nam S; Cai Q; Long X
Biomed Res Int; 2014; 2014():724209. PubMed ID: 25157366
[TBL] [Abstract][Full Text] [Related]
3. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis.
Pan F; Mao H; Deng L; Li G; Geng P
Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203
[TBL] [Abstract][Full Text] [Related]
6. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
Dong LL; Chen LM; Wang WM; Zhang LM
Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
[TBL] [Abstract][Full Text] [Related]
10. Clinical aspects of circulating miRNA-335 in breast cancer patients: A prospective study.
Swellam M; Mahmoud MS; Hashim M; Hassan NM; Sobeih ME; Nageeb AM
J Cell Biochem; 2019 Jun; 120(6):8975-8982. PubMed ID: 30506730
[TBL] [Abstract][Full Text] [Related]
11. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
[TBL] [Abstract][Full Text] [Related]
12. Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer.
Cheng CW; Yu JC; Hsieh YH; Liao WL; Shieh JC; Yao CC; Lee HJ; Chen PM; Wu PE; Shen CY
Cell Physiol Biochem; 2018; 48(5):2205-2218. PubMed ID: 30110679
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
[TBL] [Abstract][Full Text] [Related]
14. The association of D-dimer with clinicopathological features of breast cancer and its usefulness in differential diagnosis: A systematic review and meta-analysis.
Lu Y; Zhang L; Zhang Q; Zhang Y; Chen D; Lou J; Jiang J; Ren C
PLoS One; 2019; 14(9):e0221374. PubMed ID: 31487295
[TBL] [Abstract][Full Text] [Related]
15. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
16. Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer.
Pishbin F; Ziamajidi N; Abbasalipourkabir R; Najafi R; Farhadian M
Per Med; 2021 Jan; 18(1):31-42. PubMed ID: 33393369
[No Abstract] [Full Text] [Related]
17. Prognostic and biological significance of microRNA-127 expression in human breast cancer.
Wang S; Li H; Wang J; Wang D; Yao A; Li Q
Dis Markers; 2014; 2014():401986. PubMed ID: 25477702
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
Zheng M; Sun X; Li Y; Zuo W
Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
[TBL] [Abstract][Full Text] [Related]
19. Breast tissue-based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer.
Eissa S; Matboli M; Shehata HH
Transl Res; 2015 Mar; 165(3):417-27. PubMed ID: 25445205
[TBL] [Abstract][Full Text] [Related]
20. Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters.
Swellam M; El Magdoub HM; Hassan NM; Hefny MM; Sobeih ME
Clin Biochem; 2018 Jun; 56():47-54. PubMed ID: 29679553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
